← Leaderboards
Li Sun
Icahn School Of Medicine At Mount Sinai
$3,167,852
Attributed
$7,682,237
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $924.4K · FY2009–24$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,682,237 · 4
By mechanism
R01$4,039,598 · 2
R44$3,642,639 · 2
Top collaborators
- Terry Francis Davies8 shared
- Mone Zaidi8 shared
- David T Fung6 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Mone Zaidi$25,912,145
- Alice H Huang$6,887,706
- Nelly Andarawis-Puri$5,304,500
- Jameel Z Iqbal$529,708
- Sarah E Millar$29,975,437
Others in their field
Top investigators on “Chronic”
- Judith S. Currier · University Of California Los Angeles$245,012,139
- Lawrence Corey · Fred Hutchinson Cancer Center$209,947,290
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$201,828,077
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$173,476,538
- John M Lachin · George Washington University$125,152,883
- David M Nathan · Massachusetts Institute Of Technology$120,438,756
Research focus
ChronicRattusFutureAffectBone DiseasesHyperthyroidismImpairmentDeteriorationExcisionEffective TherapyBone ResorptionAgonistBone CellAmericanBoneBone LossCoculture TechniquesAnterior Pituitary HormonesAdverse EffectsCytokineCellsDoseCommercializationFracture
Grant awards (14)
miRNA drug for tendinopathy$560,060
R44 · FY2024 · AG
miRNA drug for tendinopathy$568,966
R44 · FY2023 · AG
miRNA drug for tendinopathy$737,376
R44 · FY2022 · AG
A novel product for tendinopathy treatment$831,571
R44 · FY2021 · AG · contact PI
A novel product for tendinopathy treatment$20,300
R44 · FY2021 · AG · contact PI
A novel product for tendinopathy treatment$924,366
R44 · FY2020 · AG · contact PI
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss$590,680
R01 · FY2018 · DK
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss$627,032
R01 · FY2017 · DK
TSH and Bone$468,011
R01 · FY2013 · DK
TSH and Bone$486,297
R01 · FY2012 · DK
TSH and Bone$485,559
R01 · FY2011 · DK
TSH and Bone$537,664
R01 · FY2010 · DK
TSH and Bone$264,999
R01 · FY2010 · DK
TSH and Bone$579,356
R01 · FY2009 · DK